Anthropic Deploys Claude for Drug Discovery: Six Partners Report Tenfold Improvements in Molecular Design

Anthropic announced early progress from its Claude-powered drug discovery initiative, revealing that six partner organizations and its own in-house programs have achieved significant molecular design breakthroughs. The company, which entered the pharmaceutical sector in June 2026 with Claude Science—a research workbench for genomics and drug discovery—reported measurable improvements across multiple therapeutic areas, from antibody design to cell therapy engineering.